Physician profile
Bryan W Goss
NPI 1124021233
$6,199.49
in general payments reported to CMS, 2019-2025
53 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what 85% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $792 · 2021: $968 · 2022: $649 · 2023: $1,107 · 2024: $854 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,992 · Education: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,991.95 |
| Education | $138.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $680.58 | 2019-2025 | Opdualag, Opdivo, Krazati |
| Astrazeneca Pharmaceuticals LP | $602.66 | 2019-2025 | Imfinzi, Lynparza, Tagrisso |
| Novartis Pharmaceuticals Corporation | $463.72 | 2019-2025 | Cosentyx |
| Siemens Medical Solutions USA, INC. | $328.40 | 2023 | Truebeam |
| Janssen Biotech, INC. | $319.75 | 2019-2025 | Talvey, Darzalex, Tecvayli |
| Exelixis INC. | $281.36 | 2019-2025 | Cabometyx |
| Reflexion Medical, INC. | $213.00 | 2023 | Reflexion Medical Radiotherapy System |
| Seagen INC. | $211.76 | 2019-2023 | Tukysa, Padcev |
| Incyte Corporation | $202.66 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Merck Sharp & Dohme LLC | $169.44 | 2019-2022 | |
| Eisai INC. | $157.42 | 2019-2025 | |
| Pfizer INC. | $155.23 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.93 | 2019-2025 | |
| Genzyme Corporation | $140.28 | 2019-2025 | |
| Amgen INC. | $130.94 | 2019-2022 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Goss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.